Testing of the liquid and lyophilized formulation of a vaccine on non-pregnant women that are 18 to 40 years old to asess its safety and the protection it gives from blood poisoning caused by a bacterium Immunogenicity Objectives To demonstrate the equivalence of the liquid GBS trivalent vaccine formulation to the lyophilized GBS trivalent vaccine formulation for serotypes Ia, Ib, and III, when admin...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Trial to Assess Long-Term Persistence of Antibodies after GSK Meningococcal ABCWY Vaccination and Response to a Booster in Adolescents Effectiveness: To evaluate the effectiveness of 3 doses of MenABCWY (administered according to a 0, 2, 6-month schedule) against a randomly selected panel of US endemic N. meningitidis serogroup B in...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Revaccination of healthy non-pregnantwomen with a second dose of a vaccine to asess its safety and the protection it gives from blood poisoning caused by a bacterium Immunogenicity Objective To evaluate the immunogenicity of a second dose of GBS Trivalent Vaccine (5 μg without adjuvant) administered approximately 4-6 years after the initial GBS vaccination, measu...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A clinical study to evaluate immune responses to rabies vaccine in adults who received different primary rabies vaccination regimens Primary Objectives: Immunogenicity Objectives: 1. To compare the long-term (up to approx.10 years) persistence of antibody responses (i.e. time until antibody concentrations drop below 0.5 IU/mL) in...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune